|
[1]Wynn T.Cellular and molecular mechanisms og fibrosis[J].JPathol, 2008, 214∶199-210.
|
|
[2]Peng Z, Fernandez P, Wilder, et al.Ecto-5’-nucleotidase (CD73) -mediated extracellular adenosine production plays a criti-cal role in hepatic fibrosis[J].FASEB J, 2008, Feb 8[Epub aheadof print]
|
|
[3]Friedman SL.Hepatic stellate cells:protean, multifunctional, an-denigmatic cells of the liver[J].Physiol Rev, 2008, 88∶125-172.
|
|
[4]Kato J, Iao A, Hasuike S, et al.Transforming growth factorβin-duced stimulation of formation of collagen fiber network and anti-fi-brotic effort of taurinein an in vitro model of hepatic fibrosis[J].Hepatology Research, 2004, 30∶34-41.
|
|
[5]徐勤.核因子κB在肝纤维化中作用的研究进展[J].国际病毒学杂志, 2006, 13∶167-170.
|
|
[6]成杨, 平键, 徐列明.姜黄素上调PPAEγ抑制肝星状细胞活化标志表达的研究[J].中国实用内科杂志, 2006, 1∶22-24.
|
|
[7]Saleh HA, Abu-Rashed AH.Liver biopsy remains the gold stam-dard for evaluation of chronic hepatitis and fibrosis[J].J Gastrointes-tin Liver Dis, 2007, 16∶263-266.
|
|
[8]Rose E, Adams L, Prins A, et al.Validation of the fibro test bio-chemical markers score in assessing liver fibrosis in hepatitis C pa-tients[J].Clin Chem, 2003, 49∶450-454.
|
|
[9]de Ledinghen V, Barreiro P, Foucher J, et al.Liver fibrosis on ac-count of chronic hepatitis C is more severe in HIV-positive thanHIV-negative patients despite antiretroviral therapy[J].J ViralHepat, 2008, 22[Epub ahead print].
|
|
[10]de Ledinghen V, Le Bail B, Rehouissoux L, et al.Liver stiffnessmeasurement in children using FibroScan:feasibility study and com-parison with Fibrotest, aspartate transsminase to platelete ratio in-dex, and liver biopsy[J].J Pediatr Gastroenterol, 2007, 45∶443-450.
|
|
[11]Schmilovitz-Weiss H, Niv Y, Pappo o, et al.The13C-caffeinebreath test detects significant fibrosis with nonalcoholic steatohepati-tis[J].J Clin Gastroenterol, 2008, 13[Epub ahead print]
|
|
[12]池肇春.慢丙肝抗病毒治疗的现状与策略[J].医师进修杂志, 2005, 28∶1-3.
|
|
[13]池肇春.慢乙肝肝硬化时的抗病毒治疗[J].中西医结合肝病杂志, 2006, 16∶129-132.
|
|
[14]Inagaki Y, Kushida M, Higashi K, et al.Cell type-specific inter-vention of transforming growth facotr beta/Smad signaling suppressescollagen gene expression and hepatic fibrosis in mice[J].Gastroen-terology, 2005, 129∶268-295.
|
|
[15]Iimuro Y, Nishio T, Morimoto T, et al.Delivery of matrix netalloproteinase-1 attenuates established liver fibrosis I the ray[J].Gas-troenterology, 2003, 124∶445-448.
|
|
[16]Bueno M, Salgado S, Beas-zarate C, et al.Urokinase-type plas-minogen activator gene therapy in liver cirrhosis is mediatedby colla-gens gene expression down-regulation of MMMPs, HGF andVEGF[J].Gene Med, 2006, 8∶1291-1299.
|
|
[17]Wang CH, Lee TH, Lu CN, et al.Eletroporative alpha-MSHgenetransfer attenuates tkioacelamide-ibduced murine hepatic fibrosis byMMP and TIMP mmmodulation[J].Gene Ther, 2006, 13∶1000-1009.
|
|
[18]Cheng JH, She H, Han YP, et al.Wnt antagonism inhibits hepaticstellate cell activation and liver fibrosis[J].Am j Physiol Gastroint-est Liver Physiol, 2008, 294∶G59-49.
|
|
[19]George J, Tsutsumi M.SIrna-mediated knockdown of connectivetissue growth factor prevents N-nitrosodimethylamine-inducedhepstic fibrosis in rat[J].Gene Ther, 2007, 14∶790-803.
|
|
[20]Hu YB, Li DG, Lu WM, et al.Modified synthetic siRNAtargetingtissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesisin rats[J].J Gene Med, 2007, 9∶217-219.
|
|
[21]Kinoshita K, Iimuro Y, Otogawak K, et al.Adenovirus-mediatedexpression of BMP-7suppresses the development of liver fibrosis inrats[J].Gut, 2007, 56∶706-714.
|
|
[22]中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南[J].中西医结合肝病杂志, 2006, 16∶316-320.
|
|
[23]黄丽雯, 程良斌.中药以肝星状细胞为靶点的抗肝纤维化研究进展[J].中西医结合肝病杂志, 2007, 17∶191-193.
|
PDF下载 ( 317 KB)
本文二维码
下载:
